Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KX2-391 Ointment 1% in Actinic Keratosis
NCT03285490Phase 3Completed
- Sponsor
- Almirall
- Start
- Sep 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tirbanibulin in actinic keratosis (AK), sponsored by Almirall. Started Sep 2017; status: completed.
02
Drugs
tirbanibulin
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT03285490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03285490.